FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2144775456> ?p ?o ?g. }

• W2144775456 endingPage "12" @default.
• W2144775456 startingPage "508" @default.
• W2144775456 abstract "A fundamental principle in the therapeutic strategy for recurrent lymphomas is the employment of agents that are not part of the usual front line combination regimens. Ideally, the cytotoxic agents should lack complete cross resistance with those utilized up front.A three-drug combination of ifosfamide, epirubicin and etoposide (IEV) was used to treat 20 patients with relapsing or refractory high-grade non-Hodgkin's lymphoma (HG-NHL) or Hodgkin's disease (HD).Of 14 patients with HG-NHL, 5 (36%) achieved a complete response (CR) and 4 partial remission (PR), giving an overall response rate of 64%. To date, all the complete responders are still in CR at +5, +5, +6, +7, and +9 months, respectively. Of 6 patients with HD, 4 (66%) obtained CR and 2 PR, giving an overall response rate of 100%. The 4 CRs are still in remission after +4, +5, +9, and +13 months, respectively. Clinical and hematologic toxic effects were moderate: neutropenia was responsible for delaying treatment for a week in 6 patients.These results confirm the efficacy of the IEV regimen in inducing a good remission rate with moderate side effects in relapsing/refractory HG-NHL and HD patients and they show that further investigations with this combination are warranted." @default.
• W2144775456 created "2016-06-24" @default.
• W2144775456 creator A5008693201 @default.
• W2144775456 creator A5009339507 @default.
• W2144775456 creator A5015779484 @default.
• W2144775456 creator A5019650320 @default.
• W2144775456 creator A5028913158 @default.
• W2144775456 creator A5029563827 @default.
• W2144775456 creator A5034935188 @default.
• W2144775456 creator A5039992870 @default.
• W2144775456 creator A5053124026 @default.
• W2144775456 creator A5091882595 @default.
• W2144775456 date "1994-11-01" @default.
• W2144775456 modified "2023-10-16" @default.
• W2144775456 title "Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease." @default.
• W2144775456 cites W1552528426 @default.
• W2144775456 cites W1881397173 @default.
• W2144775456 cites W1899541887 @default.
• W2144775456 cites W1911120442 @default.
• W2144775456 cites W1944099139 @default.
• W2144775456 cites W1975873287 @default.
• W2144775456 cites W1979300931 @default.
• W2144775456 cites W2037366946 @default.
• W2144775456 cites W2069490418 @default.
• W2144775456 cites W2071060238 @default.
• W2144775456 cites W2073151455 @default.
• W2144775456 cites W2076668534 @default.
• W2144775456 cites W2129214379 @default.
• W2144775456 cites W2269861991 @default.
• W2144775456 cites W2273109191 @default.
• W2144775456 cites W2318772898 @default.
• W2144775456 cites W2346252839 @default.
• W2144775456 cites W2395306980 @default.
• W2144775456 cites W2409787794 @default.
• W2144775456 cites W2417789545 @default.
• W2144775456 cites W2418036853 @default.
• W2144775456 cites W2418567283 @default.
• W2144775456 cites W2433550918 @default.
• W2144775456 cites W2435402339 @default.
• W2144775456 cites W2470176307 @default.
• W2144775456 cites W590691242 @default.
• W2144775456 cites W2020184805 @default.
• W2144775456 cites W2036215958 @default.
• W2144775456 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7534744" @default.
• W2144775456 hasPublicationYear "1994" @default.
• W2144775456 type Work @default.
• W2144775456 sameAs 2144775456 @default.
• W2144775456 citedByCount "15" @default.
• W2144775456 countsByYear W21447754562015 @default.
• W2144775456 countsByYear W21447754562016 @default.
• W2144775456 countsByYear W21447754562017 @default.
• W2144775456 crossrefType "journal-article" @default.
• W2144775456 hasAuthorship W2144775456A5008693201 @default.
• W2144775456 hasAuthorship W2144775456A5009339507 @default.
• W2144775456 hasAuthorship W2144775456A5015779484 @default.
• W2144775456 hasAuthorship W2144775456A5019650320 @default.
• W2144775456 hasAuthorship W2144775456A5028913158 @default.
• W2144775456 hasAuthorship W2144775456A5029563827 @default.
• W2144775456 hasAuthorship W2144775456A5034935188 @default.
• W2144775456 hasAuthorship W2144775456A5039992870 @default.
• W2144775456 hasAuthorship W2144775456A5053124026 @default.
• W2144775456 hasAuthorship W2144775456A5091882595 @default.
• W2144775456 hasConcept C121332964 @default.
• W2144775456 hasConcept C126322002 @default.
• W2144775456 hasConcept C141071460 @default.
• W2144775456 hasConcept C142424586 @default.
• W2144775456 hasConcept C143998085 @default.
• W2144775456 hasConcept C2776694085 @default.
• W2144775456 hasConcept C2776755627 @default.
• W2144775456 hasConcept C2777063308 @default.
• W2144775456 hasConcept C2777506904 @default.
• W2144775456 hasConcept C2778119113 @default.
• W2144775456 hasConcept C2778822529 @default.
• W2144775456 hasConcept C2779338263 @default.
• W2144775456 hasConcept C2780835546 @default.
• W2144775456 hasConcept C71924100 @default.
• W2144775456 hasConcept C87355193 @default.
• W2144775456 hasConcept C90924648 @default.
• W2144775456 hasConceptScore W2144775456C121332964 @default.
• W2144775456 hasConceptScore W2144775456C126322002 @default.
• W2144775456 hasConceptScore W2144775456C141071460 @default.
• W2144775456 hasConceptScore W2144775456C142424586 @default.
• W2144775456 hasConceptScore W2144775456C143998085 @default.
• W2144775456 hasConceptScore W2144775456C2776694085 @default.
• W2144775456 hasConceptScore W2144775456C2776755627 @default.
• W2144775456 hasConceptScore W2144775456C2777063308 @default.
• W2144775456 hasConceptScore W2144775456C2777506904 @default.
• W2144775456 hasConceptScore W2144775456C2778119113 @default.
• W2144775456 hasConceptScore W2144775456C2778822529 @default.
• W2144775456 hasConceptScore W2144775456C2779338263 @default.
• W2144775456 hasConceptScore W2144775456C2780835546 @default.
• W2144775456 hasConceptScore W2144775456C71924100 @default.
• W2144775456 hasConceptScore W2144775456C87355193 @default.
• W2144775456 hasConceptScore W2144775456C90924648 @default.
• W2144775456 hasIssue "6" @default.
• W2144775456 hasLocation W21447754561 @default.
• W2144775456 hasOpenAccess W2144775456 @default.
• W2144775456 hasPrimaryLocation W21447754561 @default.

• next